Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medicus Pharma Ltd
V.MDCX
Alternate Symbol(s):
MDCX
|
MDCXW
Healthcare
Biotechnology
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets. Its subsidiaries include SkinJect, Inc, and Medicus Pharma Inc. The Company’s wholly owned subsidiary, SkinJect, Inc (SkinJect), is focused on commercializing a novel, non-invasive treatment for basal cell skin cancer using a patented...
dissolvable microneedle patch to deliver chemotherapeutic agent to eradicate tumor cells. The Company’s wholly owned subsidiaries are focused on the development of a drug delivery system using a dissolvable microneedle array for the treatment of certain skin cancers. The Company investigates opportunities across all therapeutic areas where an unmet need exists for improved patient safety and efficacy. The Company is actively exploring expanding its drug development pipeline through qualified and accretive acquisitions and partnerships.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:MDCX)
New Post
View:
Posts & Comments
Threaded Posts
(16)
•••
Jolly09
X
View Profile
View Bullboard History
Post by
Jolly09
on Nov 13, 2024 7:07pm
NASDAQ Listing
I think the share consolidation and uplisting to NASDAQ is the right move. https://stockhouse.com/news/press-releases/2024/11/13/medicus-pharma-ltd-announces-pricing-of-us-4-0m-initial-public
...more
(14)
•••
LingMai2024
X
View Profile
View Bullboard History
Post by
LingMai2024
on Jun 28, 2024 8:47am
Ackers Bioscience Another Company Raza Bokhari involved
https://www.globenewswire.com/news-release/2015/11/12/786555/29748/en/Akers-Biosciences-Appoints-Dr-Raza-Bokhari-as-Non-executive-Director.html What's the current stock price?
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 23, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(14)
•••
LingMai2024
X
View Profile
View Bullboard History
Post by
LingMai2024
on Jun 28, 2024 8:46am
Raza Bokhari Hired Steven Buyer - Who was charged by SEC
Also note While Raza Bokhari was the CEO of FSD Pharma he had hired Steven Buyer https://www.newswire.ca/news-releases/fsd-pharma-appoints-former-member-of-u-s-congress-to-its-board-of-directors
...more
(14)
•••
LingMai2024
X
View Profile
View Bullboard History
Post by
LingMai2024
on Jun 28, 2024 8:22am
Todays News Release FSD Pharma Vs Raza Bokhari Lawsuit
The recent news about FSD Pharma winning a final judgment against former CEO Raza Bokhari is highly significant for shareholders for several reasons: Validation of FSD's Actions: The
...more
(14)
•••
LingMai2024
X
View Profile
View Bullboard History
Post by
LingMai2024
on May 31, 2024 9:15am
MDCX CEO Raza Bokahri Owes FSD Pharma Shareholders Millions
These legal awards are owing to FSD Pharma and it's shareholders by the current chairman and CEO of Medicus Pharma Dr. Raza Bokhari Do your own Due Diligence if thinking of investing these are
...more
(516)
•••
TrevorAbes
X
View Profile
View Bullboard History
Post by
TrevorAbes
on Mar 22, 2024 9:26am
Three cheap tech stocks solving multi-billion-dollar problem
https://stockhouse.com/news/newswire/2024/03/22/three-cheap-tech-stocks-solving-multi-billion-dollar-problems
(0)
•••
RichardBlack
X
View Profile
View Bullboard History
Post by
RichardBlack
on Feb 06, 2024 8:31am
Raza Bokhari the ceo of medicus owes alot of money
Hey guys just wanted to share for due diligence Raza Bokhari the ceo of Medicus owes alot of money to FSD Pharma because he lost multiple times in court and now has to pay $3,000,000 with
...more
(516)
•••
TrevorAbes
X
View Profile
View Bullboard History
Post by
TrevorAbes
on Jan 03, 2024 10:47am
Biotech stock reports FDA submission 3 months after listing
https://stockhouse.com/news/the-market-herald-news/2024/01/03/biotech-stock-reports-fda-submission-only-3-months-after-listing
(516)
•••
TrevorAbes
X
View Profile
View Bullboard History
Post by
TrevorAbes
on Oct 13, 2023 10:05pm
MDCX in Three small-cap growth stocks shooting for the moon
https://themarketherald.ca/three-small-cap-growth-stocks-shooting-for-the-moon-2023-10-13/
(516)
•••
TrevorAbes
X
View Profile
View Bullboard History
Post by
TrevorAbes
on Oct 11, 2023 11:22am
A holding company to supercharge your healthcare allocation
https://themarketherald.ca/medicus-pharma-a-holding-company-to-supercharge-your-healthcare-allocation-2023-10-11/
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >